NLSP — Stock activity · TradeandTellNLSP
NLSP
$7.62+$0.22 (+2.97%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$7.40 – $28.03
1% from low
Held by traders on TradeandTell
No one on the platform currently holds NLSP.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NLSP as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|
| 2025-10-31 | 1-for-10reverse |
| 2024-09-27 | 1-for-40reverse |
Recent trades on TradeandTell
No one on the platform has traded NLSP yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $133M | — | $45.20 | $45.20–$45.20 | 0.2× | 1 |
| 2027 | $179M | +34.8% | $68.80 | $68.80–$68.80 | 0.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 5 of the last 5 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2024-05-15 | $-8.40 | $-0.00 | +100.0% |
| 2023-06-30 | $-6.80 | $-0.20 | +97.1% |
| 2023-05-05 | $-12.00 | $-0.29 | +97.5% |
| 2022-03-24 | $-13.80 | $-0.50 | +96.4% |
| 2021-05-14 | $-6.80 | $-0.34 | +95.0% |
DCF fair valuemodel estimate
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| NLSPNLS Pharmaceutics AG | $2.91 | -12.61% | $919601 | — |
| BACKIMAC Holdings, Inc. | $0.00 | +0.00% | $1892 | — |
| BCTXWBriaCell Therapeutics Corp. | $0.00 | -0.00% | $1695 | — |
| CELUCelularity Inc. | $0.70 | +0.69% | $20M | — |
| CEROCERo Therapeutics Holdings, Inc. | $0.01 | +14.74% |
| KTTAPasithea Therapeutics Corp. | $0.49 | +3.20% | $16M | — |
| NUWENuwellis, Inc. | $1.34 | +3.08% | $123549 | — |
Source: Financial Modeling Prep · peers by sector/industry